CI Global Investments’s Biogen BIIB Stock Holding History

CI Global Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-25,000	Closed	-$10.6M	–	152
2015 Q1	$10.6M	Hold	25,000	–	–	0.23%	84
2014 Q4	$8.49M	Sell	25,000 -60,000	-71%	-$19.4M	0.17%	91
2014 Q3	$28.1M	Sell	85,000 -5,000	-6%	-$1.65M	0.64%	45
2014 Q2	$28.4M	Hold	90,000	–	–	0.72%	39
2014 Q1	$27.5M	Buy	+90,000	New	+$28.6M	0.73%	38

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CI Global Investments's BIIB Position: Q2 2015 in Review

CI Global Investments sold out of Biogen (BIIB) in Q2 2015, closing a stake of 25,000 shares — an estimated $10.6M sold.

CI Global Investments first reported a position in BIIB in Q1 2014 and held it in 5 quarters. The position peaked at $28.4M in Q2 2014. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

CI Global Investments reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
CI Global Investments sold 25,000 Biogen shares in Q2 2015, an estimated $10.6M.
CI Global Investments first reported a position in Biogen in Q1 2014 and held it in 5 quarters.
CI Global Investments's Biogen position peaked at $28.4M in Q2 2014.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on CI Global Investments's 13F filing for Q2 2015, filed 12 Aug 2015.